INTECH Investment Management’s Stoke Therapeutics STOK Stock Holding History

INTECH Investment Management’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$472K	Sell	14,494 -4,158	-22%	-$136K	﹤0.01%	1356
2025 Q4	$592K	Buy	18,652 +5,505	+42%	+$165K	0.01%	1417
2025 Q3	$309K	Sell	13,147 -5,070	-28%	-$86.9K	﹤0.01%	1812
2025 Q2	$207K	Sell	18,217 -4,117	-18%	-$39.1K	﹤0.01%	2073
2025 Q1	$149K	Buy	22,334 +5,918	+36%	+$55.2K	﹤0.01%	2200
2024 Q4	$181K	Buy	16,416 +3,364	+26%	+$41.3K	﹤0.01%	2061
2024 Q3	$160K	Buy	+13,052	New	+$185K	﹤0.01%	1789

Other funds holding STOK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

INTECH Investment Management's STOK Position: Q1 2026 in Review

INTECH Investment Management reduced its Stoke Therapeutics (STOK) stake by 22% in Q1 2026, selling an estimated $136K and leaving 14,494 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #1356.

INTECH Investment Management first reported a position in STOK in Q3 2024 and has held it in 7 quarters since. The position peaked at $592K in Q4 2025. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

INTECH Investment Management held 14,494 shares of Stoke Therapeutics worth $472K as of Q1 2026.
INTECH Investment Management sold 4,158 Stoke Therapeutics shares in Q1 2026, an estimated $136K.
Stoke Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1356 holding.
INTECH Investment Management first reported a position in Stoke Therapeutics in Q3 2024 and has held it in 7 quarters since.
INTECH Investment Management's Stoke Therapeutics position peaked at $592K in Q4 2025.
196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.